Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape

Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape



This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

This report gives an important expert quantitative analysis on the COVID-19 contract vaccine manufacturing industry.
- Findings are based on the industrys most comprehensive database of the Pharma industry (Pharma Intelligence Center). The 11 tables and 23 figures throughout the report illustrate major points and trends.

Reasons to Buy

- What are the pipeline COVID-19 prophylactic vaccines by developer type?
- What are the top pipeline COVID-19 prophylactic vaccines analyst consensus sales forecast?
- What is the distribution of COVID-19 prophylactic vaccines clinical trials?
- What and Where are CMOs vaccine manufacturing facilities?
- What are the COVID-19 vaccine contract manufacturing service agreements by Molecule Type?
- What are the COVID-19 vaccine contract manufacturing service agreements by Service?
- What are the COVID-19 vaccine contract manufacturing service agreements by CMO?
- What are the COVID-19 vaccine contract manufacturing service agreements by Sponsor?

1 Executive Summary
2 Players
3 Technology Briefing
3.1 What is COVID-19?
3.2 COVID-19 Pipeline Vaccine Types and Technology
4 Trends
5 Industry Analysis
5.1 COVID-19 Pipeline Vaccines
5.2 COVID-19 Vaccine Projected Sales
5.3 Contract Manufacturing Capabilities for Vaccines
5.4 COVID-19 Vaccine Contract Service Agreements
5.5 Investors in COVID-19 Vaccine Manufacturing
5.5.1 Governments
5.5.2 Pharma Companies
5.5.3 CMOs
6 Value Chain
7 Companies
8 Appendix
8.1 Methodology
8.2 Bibliography
8.3 Primary Research - Key Opinion Leaders
8.4 Further Reading
9 About the Authors

List Of Tables

Table 1: COVID-19 Vaccine Trends, 2020
Table 2: Highest Development (Phase II-Marketed) COVID-19 Vaccines, 2020
Table 3: Likelihood of Approval for Infectious Disease Vaccines, 2020
Table 4: Promising COVID-19 Vaccines with Fast Track, WARP, ESI and Rolling Submission Status 2020
Table 5: COVID-19 Vaccine Contract Manufacturing Service Agreements, 2020
Table 6: Government and Non-Governmental Organization Funding Announcements, 2020
Table 7: Pharma Funding Events, 2020
Table 8: CMO Funding Events, 2020
Table 9: CMOs with COVID-19 Vaccine Contract Service Agreements
Table 10: Pharma Company Sponsors with COVID-19 Vaccine Pipeline Drugs
Table 11: Further Reading

List Of Figures

Figure 1: Leading Players for COVID-19 Vaccine Manufacturing and their Place on the Value Chain
Figure 2: COVID-19 Virus Life Cycle
Figure 3: Top COVID-19 Vaccine Trends, 2020
Figure 4: COVID-19 Pipeline Vaccines by Highest Phase, 2020
Figure 5: COVID-19 Pipeline Drugs Type by Highest Phase, 2020
Figure 6: Most Active COVID-19 Vaccine Sponsors Across All Stages of Development, 2020
Figure 7: Most Active COVID-19 Vaccine Developers in Phase II-III, 2020
Figure 8: Clinical Trials (Phases I-III) for COVID-19 Prophylactic Vaccines by Site Location, 2020
Figure 9: COVID-19 Prophylactic Vaccine Pipeline by Developer Type, 2020
Figure 10: COVID-19 Prophylactic Vaccine Global Analyst Consensus Sales Forecast ($B)
Figure 11: COVID-19 Prophylactic Vaccines Global Analyst Consensus Sales Forecast
Figure 12: Contract Manufacturing Vaccine API Facilities, 2020
Figure 13: Top CMOs by Contract Vaccine API Manufacturing Facilities, 2020
Figure 14: Geographic Distribution of Contract Vaccine API Facilities, 2020
Figure 15: Outsourcing of Currently Approved US Vaccines, 2020
Figure 16: COVID-19 Vaccine Contract Manufacturing Service Agreements by Molecule Type, 2020
Figure 17: COVID-19 Vaccine Contract Manufacturing Service Agreements by Service, 2020
Figure 18: Top Vaccines by Number of Contract Manufacturing Service Agreements, 2020
Figure 19: Contract Service Agreements by Deal Country, 2020
Figure 20: CMOs by Most COVID-19 Vaccine Contract Service Agreements, 2020
Figure 21: Pharma Sponsors by Most COVID-19 Vaccine Contract Service Agreements, 2020
Figure 22: Contract Manufacturing Service Agreements and Global COVID-19 Deaths in 2020
Figure 23: The Contract Manufacturing Value Chain

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available